Back to search

Article

Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assays

2023-08-25

Abstract excerpt

<h4>Background</h4> Increased levels of glial fibrillary acidic protein (GFAP) in blood have been identified as a valuable biomarker for some neurological disorders, such as Alzheimer’s disease and multiple sclerosis. However, most blood GFAP quantifications so far were performed using the same bead-based assay, and to date a routine clinical application is lacking. <h4>Methods</h4> In this study, we validated a n...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4b292a70-7bdf-5eff-8072-10a57009f2e5
DOI
10.1101/2023.08.24.23294528
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assaysDOI 10.1101/2023.08.24.23294528
Select a neighboring publication to make it the new centre.